The adult mammalian central nervous system (CNS) fails to regenerate its axons following injury. A comparison between its postinjury response and that of axons of nervous systems capable of regeneration reveals major differences with respect to inflammation. In regenerative systems, a large number of macrophages rapidly invade the injured site during the first few hours and days after the injury. Following their activation/differentiation through interaction with the host tissue, they play a central role in tissue healing through phagocytosis of cell debris and communication with cellular and molecular elements of the damaged tissue. Relative to the peripheral nervous system (PNS), macrophage recruitment in the adult mammalian CNS is delayed and is restricted in amount and activity. It was recently proposed that in injured mammalian CNS tissue, implantation of macrophages stimulated by prior co-culture with segments of peripheral (sciatic) nerves can compensate, at least in part, for the restricted postinjury inflammatory reaction. In the present study, this experimental paradigm is further explored and shows that there is no conflict between the systemic use of anti-inflammatory compounds and treatment with stimulated macrophages to promote regrowth of neuronal tissue.
Introduction
At least some injured mammalian central nervous system (CNS) axons can, under certain conditions, be induced to grow for considerable distances (David and Aguayo, 1981; Lavie, Murray, Solomon, Ben-Bassat, Belkin, Rumelt and Schwartz, 1990; Schnell and Schwab, 1990) . This may suggest that properties or processes other than an intrinsic inability to regrow may be the cause of regeneration failure following CNS injury. A comparison between the extracellular milieu of axons of mammalian and nonmammalian CNS reveals a marked difference in the appearance, distribution, and relative proportions of their immune cells (Dowding & Scholes, 1993) . Moreover, the resident macrophages (microglia) of the mammalian CNS are thought to be in a down-regulated state relative to the resident macrophages of other systems (Jordan and Thomas, 1988; Thomas, 1992; Dowding and Scholes, 1993; Jiang, Streilein and McKinney, 1994) .
Comparative studies of regenerative and nonregenerative neural systems suggest that at least some of the difference between their regrowth capabilities may be attributable to the differences in the response of nonneuronal cells associated with the injured axons. Such a response might be a reflection of the nature of the postinjury inflammatory reaction of the injured tissue. It was shown, for example, that Wallerian degeneration and clearance of myelin debris, both known to be performed by macrophages, are delayed in the CNS in comparison to the PNS (George and Griffin, 1994) . In addition, in the injured PNS, secretion of neurotrophic factors such as nerve growth factor (NGF) and proliferation of Schwann cells are thought to be modulated by macrophages (Heumann, Lindholm, Bandtlow, Meyer, Radeke, Misko, Shooter and Thoenen, 1987) . Similarly, macrophage-derived factors have been shown in vitro to have beneficial effects on wounded astrocytes in terms of their migration ability and/or scar formation (FaberElman, Lavie, Schvartz, Shaltiel and Schwartz, 1995) . Taken together, these studies suggest that in mammals the dialog between the immune cells and the damaged nerves in the PNS differs from that in the CNS in a way that might explain the difference in their regeneration. Support for this notion comes from the finding that in the mammalian CNS, recruitment of blood-borne monocytes to the injury site is delayed and restricted relative to the PNS (Perry et al., 1987; Avellino, Hart, Dailey, MacKinnon, Ellagala and Kliot, 1995) . Furthermore, exposure of blood-borne-monocytes to nerve segments of the CNS, but not of the PNS, results in suppression of their migration, adhesion, phagocytosis and NO production (Hirschberg and Schwartz, 1995; Ben Zeev-Brann, Lazarov-Spiegler, Brenner and Schwartz, 1998) . The suppression was shown to result, at least in part, from the presence of an inhibitory molecule that resides in the CNS, and which may be a part of the 'immune privilege' mechanism of the mammalian CNS (Hirschberg and Schwartz, 1995; Beserman, Hershkovitz, Lider, Kesler, Muller, Hirschberg, Schwartz (unpublished) ). Accordingly, it seems reasonable to suggest that although the restricted communication between the nervous and immune systems may be of advantage to the intact adult mammalian CNS, its persistence after injury may obstruct postinjury processes needed for regeneration.
In the present study, adult rat blood-borne monocytes were isolated and stimulated ex vivo by incubation for 2 or 24 h with a PNS (sciatic) nerve. The stimulated macrophages were then implanted into completely transected adult rat optic nerve. Regrowth was assessed 7-8 weeks later by applying a dye distally to the site of the lesion in such a way that only axons that had grown as far as the site of the dye application could take up the dye and transport it to their cell bodies. Thus, assessment of the number of labeled retinal ganglion cells using this method is a measure of regrowth. Systemic application of the anti-inflammatory agent dexamethasone, shown to affect rescue of spored neurons (Hirschberg et al., 1994) together with implantation of the stimulated macrophages did not reduce the effect of growth-promoting macrophages on axonal regrowth.
Materials and methods

Preparation of monocytes and their incubation with ner6e segments
Peripheral blood monocytes were obtained from adult male Sprague-Dawley (SPD) rats by one-step Percoll gradient fractionation (Hirschberg and Schwartz, 1995) . Briefly, 10 ml of blood were withdrawn from the animal's heart into a 10-ml syringe coated with heparin (5000 U/ml, Calbiochem, La Jolla, CA), and were diluted (v:v) with phosphatebuffered saline (PBS) and subjected to Percoll fractionation (1.077 g/ml Percoll, Pharmacia, Sweden). The gradient was performed following centrifugation for 25 min at 30°C in a rotating Sorvall centrifuge at 291× g. The monocyte-enriched fraction was recovered at the interface and washed once with PBS to remove Percoll traces. The cells were resuspended in DCCM-1 medium (Beit Ha'emek, Israel) (1×10 6 cells/ml) and cultured in Teflon bags or polypropylene tubes to prevent adherence and thus nonspecific activation. Monocytes were incubated with freshly excised nerve segments of rat or mouse sciatic nerve for 24 h (5×10 6 cells/nerve segment). In a few experiments, incubation was carried out for 2 h was found to be long enough for activation (Ben Zeev-Brann et al., 1998) . Sciatic nerve segments of uniform length (5-10 mm) were used in all implantation experiments to ensure a constant ratio of nerve length to macrophage number. The sciatic nerve segments were then removed and the monocytes were washed once with PBS to remove traces of soluble substances derived from the nerve, and resuspended in DCCM-1 medium (2.5-5× 10 6 cells/ml). Monocytes that were exposed to nerve segments are referred to hereafter as macrophages.
Optic ner6e transection and macrophage implantation
Adult male SPD rats, 8-10 weeks old and weighing around 300 g, were deeply anesthetized (xylazine 50 mg/kg and ketamine 35 mg/kg), their left optic nerve was exposed by lateral canthotomy, the conjuctiva was incised lateral to the cornea and the retractor bulbi muscles were separated. Through a small opening in the meninges (approximately 200 mm) the nerve fibers were completely transected 2-3 mm from the globe, without damage to the nerve vasculature and with minimal damage to the meninges, by the use of a specially designed glass dissector with a 200-mm tip and a smooth blunt edge (Solomon, Lavie, Hauben, Monsonego, Yoles and Schwartz, 1996) . Immediately after optic nerve transection, 2 ml of macrophage suspension (2.5× 10 3 − 1× 10 4 cells) in DCCM-1 medium were implanted into the site of transection using a specially designed glass micropipet. In control animals, 2 ml of DCCM-1 medium were applied to the injury site. The injury was unilateral in all animals.
Retrograde labeling of retinal ganglion cells
Between 7 and 8 weeks after optic nerve transection the animals were deeply anesthetsized. Small crystals of the lipophilic neurotracer dye 4-(4-(didecylamino)styryl)-N-methylpyridinium iodide (4-Di-10-Asp) (Molecular Probes, Netherlands) were dissolved Fig. 1 . Incubation time needed for ex vivo stimulation of blood-borne monocytes. Macrophages were incubated for (a) 24 h or (b) 2 h with sciatic nerve segments and then implanted into the site of injury of optic nerve immediately after its transection. Regrowing axons were assessed by application of a dye distally to the site of the injury in such a way that it could be taken up only by axons that grow at least as far as the site of the dye application. Since these axons transport the dye to their cell bodies, the number of labeled cell bodies is a measure of the number of regrowing axons. Labeled retinal ganglion cells could be detected in optic nerves implanted with macrophages incubated for 24 h, as well as optic nerves implanted with macrophages incubated for 2 h. Each symbol in the graph represents one animal. Hardly any labeled retinal ganglion cells were observed in retinas of axons of nonimplanted optic nerves. Both treatments yielded significantly better results than those obtained in the nonimplanted group (P= 0.0001), according to a statistical comparison using GLM with a Poisson link function.
gently in incomplete Freund's adjuvant (Difco, Detroit, MI) and applied to the transected nerve 2 mm from the distal border of the injury site (the site of injury is 2 -3 mm from the globe, the width of the site is approximately 2 -3 mm and therefore application of the dye 2 mm from the distal border of the site adds to a distance of approximately 8 mm from the globe). The site of injury by this time was visible by its grayish color in comparison to the rest of the nerve, which maintained its original color. A week after dye application retinas were excised, whole-mounted on millipore filters and fixed in 4% paraformaldehyde, and the numbers of labeled retinal ganglion cells were counted by fluorescence microscopy. Differences between the groups were analyzed statistically using GLM with a Poisson link function.
Dexamethasone injection
Immediately after optic nerve transection and implantation (using macrophages incubated with sciatic nerve segments for 24 h), dexamethasone sodium phosphate (Dexacort, 4 mg/ml; Teva, Israel) was injected intraperitoneally at a dosage of 2.4 mg/kg. There were two groups of macrophage-treated animals. Rats in the first group were treated with macrophages only. Rats in the second group were treated with macrophages and were injected systemically with dexamethasone.
Results
Detection of regrowing axons following implantation of stimulated macrophages into completely transected adult rat optic ner6e
It was previously demonstrated that macrophages co-cultured with sciatic nerve segments for 24 h prior to their implantation into transected rat optic nerve are beneficial for regrowth. We examined in the present study, the effect of implanting macrophages co-cultured with sciatic nerve segments for a shorter period of time such as 2 h a time period found to be sufficient for stimulation of macrophage phagolytic activity (Ben Zeev-Brann et al., 1998) . Control optic nerves were treated with DCCM-1 only. Axonal regrowth was assessed 7-8 weeks later by counting the number of fluorescently labeled retinal ganglion cells following application of 4-Di-10-Asp distal to the site of nerve injury. Fig. 1 presents the results for all the animals tested. Each symbol in the figure represents a single retina. Hardly any labeled retinal ganglion cells were observed in the control group injected with medium only. In contrast, labeled retinal ganglion cells, indicating regrowing axons, were observed in retinas whose optic nerves had been implanted with stimulated macrophages. The maximum number of labeled retinal ganglion cells counted here, i.e. 600-800, corresponds to about 3-4% of the number observed in normal retina (approximately 21000). Statistical comparison using GLM with a Poisson link function showed that the number of labeled cells in the implanted groups differed significantly from that in the control group (P = 0.0001). As shown in Fig. 1b , the number of labeled cells in the experimental group implanted with macrophages stimulated for 2 h differed significantly from that in the control (P= 0.0001), but not from that in the group implanted with macrophages stimulated for 24 h (P = 0.133). Fig. 2 shows an example of whole-mounted retina with numerous fluorescently-labeled retinal ganglion cells. The corresponding transected optic nerve was implanted with macrophages stimulated for 24 h prior to their implantation.
Stimulation of macrophages can be achie6ed across species
To find out whether both the monocytes and the peripheral nerves used to stimulate them must be taken from the same species in order to obtain positive results, rat blood-borne monocytes were incubated with sciatic nerve of either rat or mouse prior to their implantation into the transected adult rat optic nerve. Regrowing axons, indicated by retrogradely labeled retinal ganglion cells as described above, were observed following implantation of sciatic nerve-stimulated macrophages obtained from either rat or mouse (Fig.  3) . Almost no labeled retinal ganglion cells were detectable in the retinas of nonimplanted optic nerves. The numbers of labeled retinal ganglion cells in both treated groups differed significantly from those in the control group when compared using GLM with a Poisson link function (P= 0.0001 for stimulated mouse macrophages compared with control, and P = 0.001 for stimulated rat macrophages compared with control). The median values obtained in the two experimental groups were very similar (11 and 12 for sciatic nervestimulated macrophages from mouse and rat, respectively).
Lack of suppressi6e effect of dexamethasone on macrophage-induced axonal regrowth
Previous studies have shown that nonstimulated macrophages are significantly less beneficial than sciatic nerve-stimulated macrophages for axonal regrowth in the CNS (Lazarov-Spiegler, Solomon, Ben Zeev-Brann, Hirschberg, Lavie and Schwartz, 1996) . This may suggest that the wound-healing phenotype of the prestimulated macrophages remains effective after their implantation, despite their further exposure to the CNS environment. To examine the effect of inflammation-suppressive activity on the macrophage-induced axonal regrowth, adult rats were injected intraperitoneally with the anti-inflammatory drug, dexamethasone, following complete optic nerve transection and implantation with macrophages stimulated for 24 h as described previously. An additional group of animals was implanted with macrophages but not injected with dexamethasone. Animals in the control group received dexamethasone but the site of injury was treated with medium only. The second control group was treated with medium only following optic nerve transection. Axonal regrowth was assessed by retrograde labeling of retinal ganglion cells after 7-8 weeks, as described above. As shown in Fig. 4 , dexamethasone did not cause a reduction in the number of regrowing axons obtained following macrophage implantation. The numbers of labeled retinal ganglion cells in the macrophage-implanted groups differed significantly from those in the control groups according to the statistical analysis used above (P = 0.0001). The number of labeled retinal ganglion cells in the group treated with the combination of macrophages and dexamethasone was slightly but significantly higher than in the group treated with macrophages alone, suggesting that not only does dexamethasone not interfere with the beneficial effect of the macrophages, but it may even have an additional positive effect.
Discussion
Previous studies have shown that the adult mammalian CNS contains a resident factor that suppresses macrophage activity, as shown by its inhibition of migration, adhesion, phagocytosis and NO production (Hirschberg and Schwartz, 1995; Lazarov-Spiegler et al., 1996; Ben Zeev-Brann et al., 1998) . It was postulated that such inhibition may result in restriction of the postinjury inflammatory reaction, which may in turn result in failure to achieve an optimal environment for growth, and may therefore be a cause of the failure of CNS regeneration. It was shown that implantation of stimulated macrophages into transected adult mammalian optic nerve induces axonal regrowth (LazarovSpiegler et al., 1996) . That study further suggested that macrophages prestimulated with segments of PNS axons (sciatic nerve) are more beneficial for axonal regrowth than nonstimulated macrophages. It thus seems that the implantation of stimulated macrophages compensates for the inability of the injured adult mammalian CNS to fully activate macrophages.
Incubation of macrophages for 2 h with nerve tissue capable of regeneration was found to be efficient in making them beneficial for regrowth upon implantation. It should be noted, however, that in order to estimate the duration of ex vivo macrophage stimulation which is optimally beneficial for axonal regrowth, further analysis should be carried out at additional time points and using the same macrophage preparations.
It was further shown that activation of macrophages can be achieved across species. Thus, incubation of rat macrophages with sciatic nerve of either rat or mouse resulted in similar effects. In light of these results, stimulatory signals of neural and nonneural regenerative tissues should be further compared.
To examine the ability of stimulated macrophages to induce axonal regrowth in the presence of inhibitory signals, rats were injected with the inflammation-suppressing agent dexamethasone immediately after implantation of stimulated macrophages into their transected optic nerves. The results showed that dexamethasone does not reduce the regrowth induced by the stimulated macrophages in the transected optic nerve. This might explain their ability to induce axonal regrowth in the inflammation-suppressive environment of the CNS, as compared to the much weaker induction obtained with nonstimulated macrophages. These re- Fig. 3 . Macrophage stimulation prior to implantation is effective across species. The number of regrowing axons in transected optic nerves of adult rats was compared following implantation of macrophages prestimulated with sciatic nerves of mouse or rat. Axonal regrowth was detected by retrograde labeling of retinal ganglion cells. Both treatments yielded significantly better results than those obtained in the control group (P= 0.0001 for mouse sciatic nerve stimulation versus control; P= 0.001 for rat sciatic nerve stimulation vs. control). Each symbol in each group represents one retina. Fig. 4 . Systemic application of dexamethasone in combination with implantation of stimulated macrophages. The anti-inflammatory agent dexamethasone was injected intraperitoneally into rats following implantation of stimulated macrophages into their completely transected optic nerves. Regrowing axons were detected by retrograde labeling 7-8 weeks later, as described above. Dexamethasone did not reduce the axonal regrowth induced by the stimulated macrophages, indicating that its inflammation-suppressing activity had no effect on the in vivo functioning of the implanted stimulated macrophages. The numbers of labeled retinal ganglion cells in the experimental groups differed significantly from those in the control group (P= 0.0001). Each symbol represents one retina.
sults may further suggest that anti-inflammatory agents, commonly used clinically in attempting to reduce secondary degeneration following CNS injury, can be combined with implantation of stimulated macrophages for induction of regeneration.
The current concept of CNS regeneration failure is that it is due, at least in part, to the failure of the CNS environment to support growth (David and Aguayo, 1981; Schwab and Caroni, 1988) ). It was previously proposed that even peripheral nerves are nonpermissive for axonal regrowth when in the intact state, but become permissive following injury (Bedi, Winter, Berry and Cohen, 1992) . This may suggest that the environment is rendered permissive by postinjury processes. The inflammatory reaction is one of the earliest processes to occur following injury. It was further shown that when macrophage recruitment is deficient, the regenerative process is limited (Bisby and Chen, 1990) . Accumulating evidence indicates that macrophages and macrophage-derived factors are capable of modulating the neuronal environment, making it more permissive and more supportive for axonal regrowth (Stoll, Griffin, Li and Trapp, 1989; David, Bouchard, Tsatas and Giftochristos, 1990; Lu and Richardson, 1991; Lotan, Solomon, Ben-Bassat and Schwartz, 1994; Chamak, Morandi and Mallat, 1994; Faber-Elman et al., 1995 Faber-Elman, Solomon, Abraham, Marikovsky and . Restriction of the inflammatory reaction in the CNS may explain observed phenomena such as delayed myelin clearance and delayed Wallerian degeneration (George and Griffin, 1994) .
The inability of the adult mammalian CNS to spontaneously induce a postinjury inflammatory reaction beneficial for axonal regrowth, and its need for stimulated macrophages in order to regenerate, appears to be a contradictory situation, and may suggest that CNS regeneration failure is a consequence of the development of the mammalian CNS as an immune-privileged site. It seems that immune privilege may have developed as an evolutionary device to protect the intact, highly complex mammalian CNS from immune system interference (Streilein, 1993) , but that no efficient compensatory mechanism was developed to enable regeneration to occur after injury.
